Delaware HB401 amends Title 4 to regulate hemp products, including labeling, testing, and sales restrictions.
Delaware HB401 amends Title 4 to establish a regulatory framework for hemp products, ensuring safety and compliance. The bill mandates that hemp-derived cannabinoid products (HDCP) must be tested for THC content, contaminants, and synthetic additives. It requires labels to disclose THC content, serving size, and warnings about adult use and potential impairment. The bill restricts sales to individuals 21 and older, prohibits on-site consumption, and limits THC content per serving and container.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.